Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset GL
Coverage 92,259 Raw stories ingested 7,951 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 31s ago
  • FMP Forex News Fetch every 5 min 31s ago
  • CoinGecko News Fetch every 5 min 31s ago
  • FIO Stock News Fetch every 10 min 4m ago
  • Patria Stock News Fetch every 10 min 4m ago
  • Editorial rewrite Rewrite every minute 31s ago
  • Asset sync Assets every 1 hour 24m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-07-25 16:31 11h ago
2026-07-25 04:16 23h ago
Arrowstreet Capital snížila podíl v Globe Life o 2,2 %
GL Globe Life
FMP Stock News 72
Original source text
Posted by Defense World Staff on Jul 25th, 2026

Arrowstreet Capital Limited Partnership reduced its stake in shares of Globe Life Inc. (NYSE:GL – Free Report) by 2.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,402,976 shares of the company’s stock after selling 32,271 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 1.81% of Globe Life worth $195,252,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Compound Planning Inc. raised its holdings in Globe Life by 4.3% in the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after buying an additional 82 shares during the last quarter. Root Financial Partners LLC boosted its position in shares of Globe Life by 23.3% during the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after buying an additional 83 shares during the last quarter. Transcend Capital Advisors LLC boosted its stake in shares of Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares during the last quarter. Natural Investments LLC grew its holdings in shares of Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after acquiring an additional 87 shares during the period. Finally, Parallel Advisors LLC grew its holdings in shares of Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after acquiring an additional 87 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life News Summary Here are the key news stories impacting Globe Life this week:

Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article Positive Sentiment: TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article Positive Sentiment: Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article Neutral Sentiment: Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article Negative Sentiment: Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article Insider Activity In other news, CFO Thomas Peter Kalmbach sold 7,936 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the transaction, the chief financial officer owned 50,496 shares of the company’s stock, valued at $7,907,168.64. This represents a 13.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 10,000 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. This represents a 15.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 90,187 shares of company stock worth $14,299,874 in the last 90 days. 2.11% of the stock is owned by corporate insiders.

Globe Life Stock Performance NYSE:GL opened at $173.64 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The company’s 50-day moving average price is $169.07 and its 200-day moving average price is $152.91. The company has a market cap of $13.48 billion, a P/E ratio of 11.53 and a beta of 0.47. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55.

Globe Life (NYSE:GL – Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business earned $3.05 earnings per share. The firm’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts forecast that Globe Life Inc. will post 15.67 earnings per share for the current fiscal year.

Globe Life Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Analysts Set New Price Targets A number of analysts have commented on GL shares. Morgan Stanley upped their price target on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Keefe, Bruyette & Woods decreased their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday. Jefferies Financial Group increased their price target on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. Wells Fargo & Company raised their target price on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, JPMorgan Chase & Co. increased their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and an average price target of $187.40.

Check Out Our Latest Research Report on GL

Globe Life Company Profile (Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Stories Five stocks we like better than Globe Life AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Plugging In: How Kinder Morgan Powers Up Profits

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEHubSpot (NYSE:HUBS) Price Target Cut to $217.00 by Analysts at Citigroup

NEXT HEADLINE »Arrowstreet Capital Limited Partnership Has $185.55 Million Stake in Walmart Inc. $WMT
2026-07-23 21:17 2d ago
2026-07-23 15:40 2d ago
Globe Life uspořádala konferenční hovor k výsledkům za 2. čtvrtletí 2026
GL Globe Life
FMP Stock News 78
Original source text
Globe Life Inc. (GL) Q2 2026 Earnings Call July 23, 2026 11:00 AM EDT

Company Participants

Stephen Mota - Senior Director of Investor Relations
Frank Svoboda - Co-Chairman & Co-CEO
James Darden - Co-Chairman & Co-CEO
Thomas Kalmbach - Executive VP & CFO

Conference Call Participants

Wilma Jackson Burdis - Raymond James & Associates, Inc., Research Division
Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division
Wesley Carmichael - Wells Fargo Securities, LLC, Research Division
Joel Hurwitz - Dowling & Partners Securities, LLC
Randy Binner
Pablo Singzon - JPMorgan Chase & Co, Research Division
Suneet Kamath - Jefferies LLC, Research Division
Thomas Gallagher - Evercore ISI Institutional Equities, Research Division
Maxwell Fritscher - Truist Securities, Inc., Research Division
Andrew Kligerman - TD Cowen, Research Division

Presentation

Operator

Hello, and welcome to Globe Life Inc. Second Quarter Earnings Release Conference Call. My name is Jim, and I will be your coordinator for today's event. Please note today's conference is being recorded. And during our presentation [Operator Instructions]

It is now my pleasure to hand over to your host, Stephen Mota, Vice President of Investor Relations, to begin today's conference. Thank you.

Stephen Mota
Senior Director of Investor Relations

Thank you. Good morning, everyone. Joining the call today are Frank Svoboda, and Matt Darden, our Co-Chief Executive Officer; Tom Kalmbach, our Chief Financial Officer; Mike Majors, our Chief Strategy Officer; and Brian Mitchell, our General Counsel. Some of our comments or answers to your questions may contain forward-looking statements that are provided for general guidance purposes only.

Accordingly, please refer to our earnings release, 2025 10-K, and the subsequent Forms 10-Q on file with the SEC. Some of our comments may also contain non-GAAP measures. Please see our earnings release and website for discussion of these terms and reconciliations to GAAP measures.

I will now turn the call over to Frank.
2026-07-22 23:38 3d ago
2026-07-22 18:56 3d ago
Globe Life ve 2. čtvrtletí zaostala za odhadem zisku
GL Globe Life
FMP Stock News 72
Original source text
Globe Life (GL - Free Report) came out with quarterly earnings of $3.61 per share, missing the Zacks Consensus Estimate of $3.67 per share. This compares to earnings of $3.27 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -1.64%. A quarter ago, it was expected that this life and health insurance company would post earnings of $3.46 per share when it actually produced earnings of $3.43, delivering a surprise of -0.87%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Globe Life, which belongs to the Zacks Insurance - Accident and Health industry, posted revenues of $1.59 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.22%. This compares to year-ago revenues of $1.5 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Globe Life shares have added about 31.8% since the beginning of the year versus the S&P 500's gain of 9.7%.

What's Next for Globe Life?While Globe Life has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Globe Life was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.71 on $1.61 billion in revenues for the coming quarter and $15.64 on $6.4 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance - Accident and Health is currently in the top 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Trupanion (TRUP - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This provider of medical insurance covering cats and dogs is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of -50%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Trupanion's revenues are expected to be $389.65 million, up 10.2% from the year-ago quarter.
2026-07-22 21:14 3d ago
2026-07-22 16:10 3d ago
Globe Life zvýšila EPS a zvýšila celoroční výhled
GL Globe Life
FMP Stock News 95
Original source text
, /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with $3.05 per diluted common share for the year-ago quarter. Net operating income was $3.61 per diluted common share, compared with $3.27 per diluted common share for the year-ago quarter. The Company also increased full-year 2026 earnings guidance to a range of $15.55 to $15.95, an increase of $0.10 at the midpoint.

HIGHLIGHTS:

Net income per share increased 20% and net operating income per share increased 10% over the year-ago quarter. Globe Life has produced double-digit growth in net operating income per share in eight of the last nine quarters.                 Net income as an ROE was 18.4% for the six months ended June 30, 2026. Book value per share was $78.18, an increase of 18% over the year-ago quarter. Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.3% for the six months ended June 30, 2026. Book value per share excluding AOCI was $100.04, an increase of 11% over the year-ago quarter. Total premium revenue grew 7% over the year-ago quarter.  At the American Income Life Division, life premium increased 5% and life underwriting margin increased 4% over the year-ago quarter. At the Liberty National Division, life underwriting margin increased 10% and life net sales increased 6% over the year-ago quarter. Additionally, the average producing agent count increased 8% over the year-ago quarter. At the Family Heritage Division, health underwriting margin increased 10%, health premium increased 9%, and health net sales increased 4% over the year-ago quarter. Additionally, the average producing agent count increased 7% over the year-ago quarter.  At the Direct to Consumer Division, life underwriting margin increased 10% over the year-ago quarter.  At the United American Division, health premium increased 29% and health net sales increased 10% over the year-ago quarter.   1.1 million shares of Globe Life Inc. common stock were repurchased during the quarter at a total cost of $175 million. Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

   RESULTS OF OPERATIONS

Net operating income, a non-GAAP(1) financial measure, has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company's business. Net income is the most directly comparable GAAP measure.

The following table represents Globe Life's operating summary for the three months ended June 30, 2026 and 2025:

Operating Summary

Per Share

Three Months Ended

June 30,

Three Months Ended

June 30,

2026

2025

%

Chg.

2026

2025

%

Chg.

Insurance underwriting income(2)

$       4.69

$       4.28

10

$   370,289

$   354,176

5

Excess investment income(2)

0.49

0.42

17

38,315

34,828

10

Interest on debt

(0.46)

(0.42)

10

(36,050)

(34,885)

3

Parent company expense

(0.06)

(0.04)

(4,569)

(3,555)

Income tax expense

(0.89)

(0.82)

9

(70,202)

(68,062)

3

Stock compensation benefit (expense), net of tax

(0.17)

(0.14)

(13,098)

(11,407)

Net operating income

3.61

3.27

10

284,685

271,095

5

Reconciling items, net of tax:

Realized gain (loss)

0.07

(0.18)

5,639

(14,674)

Legal proceedings

(0.03)

(0.04)

(2,577)

(3,672)

Net income(3)

$       3.65

$       3.05

$   287,747

$   252,749

Weighted average diluted shares outstanding

78,909

82,793

(1)

GAAP is defined as accounting principles generally accepted in the United States of America.

(2)

Definitions included within this document.

(3)

A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report.

Note: Tables in this earnings release may not sum due to rounding.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

MANAGEMENT VS. GAAP MEASURES

Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates. Shareholders' equity and book value per share are the most directly comparable GAAP measures. 

Six Months Ended

June 30,

2026

2025

Net income

$     558,273

$     507,312

Net operating income

558,205

530,432

Net income as an ROE(1)

18.4 %

18.8 %

Net operating income as an ROE (excluding AOCI)(1)

14.3 %

14.4 %

June 30,

2026

2025

Shareholders' equity

$   6,155,815

$   5,419,030

Impact of adjustment to exclude AOCI

1,721,729

1,983,868

Shareholders' equity, excluding AOCI

$   7,877,544

$   7,402,898

Book value per share

$        78.18

$        66.07

Impact of adjustment to exclude AOCI

21.86

24.19

Book value per share, excluding AOCI

$      100.04

$        90.26

(1)

Calculated using average shareholders' equity for the measurement period.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

INSURANCE OPERATIONS: 

Life insurance accounted for 78% of the Company's insurance underwriting margin for the quarter and 66% of total premium revenue. 

Health insurance accounted for 22% of the Company's insurance underwriting margin for the quarter and 34% of total premium revenue.

The following table summarizes Globe Life's premium revenue by product type for the three months ended June 30, 2026 and 2025:

Insurance Premium Revenue

Quarter Ended

June 30, 2026

June 30, 2025

%

Chg.

Life insurance

$       860,767

$       839,544

3

Health insurance

436,855

378,099

16

Total

$     1,297,622

$     1,217,643

7

INSURANCE UNDERWRITING INCOME

Insurance underwriting margin is management's measure of profitability of the Company's life and health segments' underwriting performance, and consists of premiums less policy obligations (excluding interest on policy liabilities), commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life and health segments, plus annuity and other income, less administrative expenses. It excludes the investment segment, interest on debt, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.

The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended June 30, 2026 and 2025:

Insurance Underwriting Income

Quarter Ended

June 30, 2026

% of

Premium

June 30, 2025

% of

Premium

%

Chg.

Insurance underwriting margins:

Life

$       359,350

42

$       340,074

41

6

Health

99,285

23

98,057

26

1

458,635

438,131

5

Annuity and other income

3,100

2,092

Administrative expenses

(91,446)

(86,047)

Insurance underwriting income

$       370,289

$       354,176

5

Per share

$             4.69

$             4.28

10

The ratio of administrative expenses to premium was 7.0%, compared with 7.1% for the year-ago quarter. 

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL 

Our distribution channels consist of the following exclusive divisions: American Income Life Division (American Income), Liberty National Division (Liberty National), Family Heritage Division (Family Heritage), Direct to Consumer Division (Direct to Consumer); and an independent agency, United American Division (United American).

Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at https://investors.globelifeinsurance.com at "Financial Reports and Other Financial Information."

Life Underwriting Margin

Quarter Ended

June 30,

2026

2025

Amount

% of Premium

Amount

% of Premium

% Chg.

American Income

$    213,604

46

$    204,533

46

4

Direct to Consumer

75,876

31

68,959

28

10

Liberty National

36,652

36

33,446

34

10

Other

33,218

67

33,136

66



Total

$    359,350

42

$    340,074

41

6

Life Premium

Quarter Ended

June 30,

2026

2025

%

Chg.

American Income

$    466,334

$    445,511

5

Direct to Consumer

244,220

246,223

(1)

Liberty National

100,516

97,263

3

Other

49,697

50,547

(2)

Total

$    860,767

$    839,544

3

Life Net Sales(1)

Quarter Ended

June 30,

2026

2025

%

Chg.

American Income

$      94,733

$      96,227

(2)

Direct to Consumer

26,578

31,096

(15)

Liberty National

26,131

24,615

6

Other

2,165

2,947

Total

$    149,607

$    154,885

(3)

(1)

Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of premium growth than annualized premium issued since annualized premium issued is before cancellations, as cancellations do not contribute to premium income.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Health Underwriting Margin

Quarter Ended

June 30,

2026

2025

Amount

% of Premium

Amount

% of Premium

% Chg.

United American

$      10,914

5

$      12,402

8

(12)

Family Heritage

45,087

36

40,927

35

10

Liberty National

23,145

49

24,372

51

(5)

American Income

18,221

59

19,325

62

(6)

Direct to Consumer

1,918

9

1,031

5

Total

$      99,285

23

$      98,057

26

1

Health Premium

Quarter Ended

June 30,

2026

2025

%

Chg.

United American

$    211,416

$    163,978

29

Family Heritage

126,273

115,856

9

Liberty National

47,403

47,631



American Income

30,805

31,422

(2)

Direct to Consumer

20,958

19,212

9

Total

$    436,855

$    378,099

16

Health Net Sales(1)

Quarter Ended

June 30,

2026

2025

%

Chg.

United American

$      27,894

$      25,454

10

Family Heritage

30,725

29,561

4

Liberty National

6,991

8,182

(15)

American Income

4,093

4,749

(14)

Direct to Consumer

696

786

(11)

Total

$      70,399

$      68,732

2

(1)

Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of premium growth than annualized premium issued since annualized premium issued is before cancellations, as cancellations do not contribute to premium income.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL

Quarterly Average

Producing Agent Count(1)

Quarter Ended

Quarter Ended

June 30,

March 31,

2026

2025

% Chg.

2026

American Income

11,391

12,241

(7)

11,064

Liberty National

4,194

3,882

8

4,031

Family Heritage

1,608

1,498

7

1,561

(1)

The quarterly average producing agent count is based on the actual count at the beginning and end of each week during the period.

INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less the required interest attributable to policy liabilities. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Excess Investment Income

Quarter Ended

June 30,

2026

2025

%

Chg.

Net investment income

$    293,820

$    282,169

4

Required interest on policy liabilities(1)

(255,505)

(247,341)

3

Excess investment income

$      38,315

$      34,828

10

Per share

$          0.49

$          0.42

17

(1)

Interest on policy liabilities, at original discount rates, is a component of total policyholder benefits, a GAAP measure.

Net investment income increased 4% and average invested assets increased 2%. Required interest on policy liabilities increased 3% and average policy liabilities increased 4%.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

The composition of the investment portfolio at book value at June 30, 2026 is as follows:

Investment Portfolio

As of

June 30, 2026

Amount

% of Total

Fixed maturities at fair value(1)

$   17,940,189

86

Mortgage loans

425,513

2

Policy loans

758,676

4

Other long-term investments(2)

1,466,858

7

Short-term investments

198,327

1

Total

$   20,789,563

(1)

As of June 30, 2026, fixed maturities at amortized cost were $19.3 billion, net of $3.3 million of allowance for credit losses.

(2)

Includes $1.10 billion of investments accounted for under the fair value option which have a cost of $1.08 billion as of June 30, 2026.

Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of June 30, 2026 are as follows:

Fixed Maturity Portfolio by Sector

As of

June 30, 2026

Investment
Grade

Below
Investment
Grade

Total
Amortized
Cost, net

Corporate bonds

$  14,797,965

$      470,927

$  15,268,892

Municipals

3,423,079

1,959

3,425,038

Government, agencies, and GSEs(1)

464,427



464,427

Other asset-backed securities

102,711

42,930

145,641

Total

$  18,788,182

$      515,816

$  19,303,998

(1)

Government-Sponsored Enterprises

Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at June 30, 2026 and the corresponding amounts of net unrealized gains and losses recognized in accumulated other comprehensive income (loss).

As of

Amortized

Cost

Allowance for
Credit Losses

Net Unrealized
Gains (Losses)

Fair

 Value

June 30, 2026

$          19,307,295

$         (3,297)

$    (1,363,809)

$    17,940,189

At amortized cost, net of allowance for credit losses, and at fair value, 97% of fixed maturities were rated "investment grade." The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.30% during the second quarter of 2026, compared with 5.29% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending.

GLOBE LIFE INC.
Earnings Release—Q2 2026
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

Comparable information for acquisitions of fixed maturity and other investments is as follows:

Fixed Maturity Acquisitions

Quarter Ended

June 30,

2026

2025

Amount

$    399,143

$    263,252

Average annual effective yield

6.3 %

6.4 %

Average rating

A

A

Average life (in years) to:

Next call

32.0

31.2

Maturity

36.1

33.8

Other Investment Acquisitions

Quarter Ended

June 30,

2026

2025

Limited partnerships

$       63,728

$       36,985

Mortgage loans

25,179

31,215

Common stock

2,340

1,342

Company owned life insurance





Total

$       91,247

$       69,542

SHARE REPURCHASES:

During the quarter, the Company repurchased 1.1 million shares of Globe Life Inc. common stock at a total cost of $175 million and an average share price of $154.28.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by volatile equity markets. Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at https://investors.globelifeinsurance.com on the Investors page under "Financial Reports and Other Financial Information."

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management's current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1) Economic and other conditions, including the impact of inflation, immigration, geopolitical events, escalating tariff and non-tariff trade measures imposed by the U.S. and other countries, and other governmental actions on the U.S. economy and/or U.S. consumer confidence, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4) Ratings changes with respect to our financial strength and credit ratings and potential adverse impacts to liquidity;

5) Interest rate changes that affect product sales, financing costs, and/or investment yields;

6) General economic, industry sector or individual debt issuers' financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may compromise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer's ability to make principal and/or interest payments due on those securities;

7) Changes in the competitiveness of the Company's products and pricing;

8) Litigation results and regulatory actions;

9) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);

10) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

11) The ability of our subsidiaries to pay dividends to the Parent Company and to receive required regulatory approvals on such amounts;

12) The customer response to new products and marketing initiatives;

13) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;

14) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;

15) The Company's ability to attract and retain agents;

16) The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and

17) Globe Life's ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission, including those described in the "Risk Factors" section of our most recent Annual Report on Form 10-K. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its second quarter 2026 earnings release conference call with financial analysts at 11:00 am (Eastern) tomorrow, July 23, 2026. Access to the live webcast and replay will be available at https://investors.globelifeinsurance.com on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at "Financial Reports."  

APPENDIX

GLOBE LIFE INC.
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Revenue:

Life premium

$      860,767

$      839,544

$   1,713,972

$   1,669,407

Health premium

436,855

378,099

853,763

747,890

Total premium

1,297,622

1,217,643

2,567,735

2,417,297

Net investment income

293,820

282,169

583,644

562,783

Realized gains (losses)

7,138

(18,574)

5,660

(18,489)

Other income

1,150

49

2,310

118

Total revenue

1,599,730

1,481,287

3,159,349

2,961,709

Benefits and expenses:

Life policyholder benefits(1)

513,959

519,355

1,032,809

1,029,111

Health policyholder benefits(2)

277,012

229,924

540,746

463,853

Other policyholder benefits

7,280

6,719

14,280

13,799

Total policyholder benefits

798,251

755,998

1,587,835

1,506,763

Amortization of deferred acquisition costs

120,537

111,401

238,819

216,916

Commissions, premium taxes, and non-deferred acquisition costs

173,754

157,411

343,640

321,734

Other operating expense

116,251

108,293

229,986

217,039

Interest expense

36,050

34,885

70,050

69,877

Total benefits and expenses

1,244,843

1,167,988

2,470,330

2,332,329

Income before income taxes

354,887

313,299

689,019

629,380

Income tax benefit (expense)

(67,140)

(60,550)

(130,746)

(122,068)

Net income

$      287,747

$      252,749

$     558,273

$     507,312

Basic net income per common share

$            3.71

$          3.09

$          7.16

$          6.13

Diluted net income per common share

$            3.65

$          3.05

$          7.04

$          6.07

(1)

Net of total remeasurement gain of $23.5 million before tax for the three months ended June 30, 2026 and a total remeasurement gain of $16.7 million before tax for the same period in 2025. Net of total remeasurement  gain of $42.4 million for the six months ended June 30, 2026, and a total remeasurement gain of $25.3 million for the same period in 2025.

(2)

Net of total remeasurement gain of $1.3 million before tax for the three months ended June 30, 2026 and a total remeasurement gain of $3.9 million before tax for the same period in 2025. Net of a total remeasurement gain of $7.3 million for the six months ended June 30, 2026, and a total remeasurement gain of $4.3 million for the same period in 2025.

SOURCE Globe Life Inc.
2026-07-09 18:45 16d ago
2026-07-09 13:01 16d ago
Globe Life zvýšila upravený EPS o 12 % v 1. čtvrtletí
GL Globe Life
FMP Stock News 78
Original source text
Key Takeaways Globe Life posted 12% operating EPS growth, supported by premium growth and disciplined underwriting. Sales momentum accelerated with health sales up 58% and life sales rising across all distribution channels. GL returned $225 million to shareholders and expects excess cash flow of $650-$700 million in 2026. Shares of Globe Life Inc. (GL - Free Report) have gained 48.7% over the past year, outperforming the industry, sector and the Zacks S&P 500 composite over the same period. The stock closed at $177.07 on Wednesday, just 2.7% below its 52-week high of $182.32, reflecting investor confidence.

Strong earnings growth, premium expansion, higher investment income and aggressive share repurchases have driven the rally. Improving investor sentiment following the easing of short-seller allegations has further supported the stock.

Image Source: Zacks Investment Research

GL has outperformed its peers, Aflac Incorporated (AFL - Free Report) and Unum Group (UNM - Free Report) , whose shares have risen 19.2% and 10.7%, respectively, in the past year, while AMERISAFE, Inc. (AMSF - Free Report) has lost 18.7%.

GL’s ValuationDespite the rally, Globe Life shares are trading at a discount compared to the industry. Its forward price-to-earnings multiple of 10.96X is lower than the industry average of 13.66X, the Finance sector’s 16.51X and the Zacks S&P 500 Composite’s 21.14X. Also, it has a Value Score of A.

Image Source: Zacks Investment Research

Shares of other insurers, such as Unum Group, are also trading at a discount, while Aflac and Amerisafe are trading at a higher multiple than the industry average.

GL’s Growth Projection EncouragesThe Zacks Consensus Estimate for Globe Life’s 2026 earnings per share (EPS) indicates a year-over-year increase of 7.7%. The consensus estimate for revenues is pegged at $6.40 billion, implying a year-over-year improvement of 6.3%.

The consensus estimate for 2027 EPS and revenues indicates an increase of 6.4% and 6.7%, respectively, from the corresponding 2026 estimates.

The company’s earnings have improved 16.1% in the past five years, better than the industry average of 0.6%.

Optimistic Analyst Sentiment on GLThe company has witnessed four upward earnings estimate revisions for 2026 over the past 60 days, against no movement in the opposite direction. For 2027, it has witnessed three upward revisions and no downward movement. Thus, the Zacks Consensus Estimate for 2026 and 2027 earnings moved 1.4% and 0.1% north, respectively, over the last 60 days.

GL’s Return on Invested CapitalThe return on invested capital in the trailing 12 months was 12.5%, better than the industry average of 6.6%. This reflects the company’s efficiency in utilizing funds to generate income.

Key Points to Note for Globe LifeGlobe Life continues to deliver strong earnings growth, supported by disciplined underwriting, healthy premium growth and prudent capital management. In the first quarter of 2026, operating EPS increased 12% year over year, marking the seventh quarter of double-digit operating EPS growth in the past eight quarters. The company also benefited from higher premiums across its Life Insurance and Health Insurance segments, providing a solid foundation for sustained earnings expansion. In the first quarter, total premiums grew 6% year over year to $1.3 billion.

Moreover, net investment income continues to be another important driver of the company’s top-line growth and has been improving over the last few years, benefiting from higher portfolio yields and disciplined investment management. The company expects investment income to continue growing in 2026, supported by elevated reinvestment yields and its conservative, high-quality investment portfolio.

Improved agent productivity, expanding distribution and growth at the American Income, Liberty National, United American and Family Heritage divisions are expected to support continued sales growth in 2026. These efforts have fueled strong sales momentum, with health sales surging 58% in the first quarter of 2026 and life sales increasing 6% across all distribution channels.

Artificial intelligence (AI) is emerging as an important long-term growth driver for Globe Life. The company expects AI to improve underwriting, claims processing, customer service, agent productivity, lower administrative expenses and drive long-term margin expansion, strengthening Globe Life's competitive position.

The company has maintained a strong liquidity position with sufficient cash-generation capabilities. For 2026, GL anticipates excess cash flow to increase to approximately $650-$700 million. Globe Life has targeted a consolidated Company Action Level RBC ratio of 300-320% for 2026.

A strong capital position enables Globe Life to enhance its shareholder value via share buybacks and dividend payouts. The company returned approximately $225 million to shareholders during the first quarter of 2026. The insurer has continuously increased its dividend over the past five years, witnessing a CAGR of 8.9%.

ConclusionGlobe Life’s higher life and health sales, improved investment income, premium growth, AI initiatives, strong liquidity position and effective capital deployment position the company well for long-term growth.

Coupled with the impressive dividend history, cheaper valuation, solid growth projections, and higher returns, as well as the optimistic analyst sentiment, the time appears right for potential investors to bet on this Zacks Rank #2 (Buy) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.